Oliver Freudenreich, MD, FACLP

Original Research

Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial

August 11, 2009

Original Research

Predictors of Early Abstinence in Smokers With Schizophrenia

November 30, 2008

Letter to the Editor

Resolution of Late-Onset Hypomania After Repair of Carotid Artery Stenosis: A Case of Vascular Hypomania

May 15, 2007

Original Research

Elevated Hemoglobin A1c as a Possible Indicator of Diabetes Mellitus and Diabetic Ketoacidosis in Schizophrenia Patients Receiving Atypical Antipsychotics

April 16, 2007

Original Research

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

May 15, 2006

Original Research

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

September 15, 2005

Original Research

Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study

September 15, 2005

Original Research

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

February 15, 2005

Original Research

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

October 15, 2004

Original Research

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

March 1, 2004

Letter to the Editor

Polypharmacy in Schizophrenia: A Fuzzy Concept

September 1, 2003

Letter to the Editor

Exacerbation of Idiopathic Priapism With Risperidone-Citalopram Combination

March 1, 2002